| Dr Hillary Ann Mitchell, MD | |
|
605 N Cleveland Massillon Rd, Suite A, Akron, OH 44333-2200 | |
| (330) 668-6545 | |
| Not Available |
| Full Name | Dr Hillary Ann Mitchell |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 605 N Cleveland Massillon Rd, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710253463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 128942 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.
The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.
As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
› Verified 1 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.
The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.
As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
› Verified 1 days ago
| Entity Name | Obstetrical & Gynecological Associates Of Akron Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861567091 PECOS PAC ID: 5496789232 Enrollment ID: O20050921000936 |
News Archive
A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.
The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.
As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hillary Ann Mitchell, MD 605 N Cleveland Massillon Rd, Suite A, Akron, OH 44333-2200 Ph: (330) 668-6545 | Dr Hillary Ann Mitchell, MD 605 N Cleveland Massillon Rd, Suite A, Akron, OH 44333-2200 Ph: (330) 668-6545 |
News Archive
A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.
The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.
As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
› Verified 1 days ago
Dr. Amy M Burkett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
David M Nash, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St, Ste 250, Akron, OH 44304 Phone: 330-375-7722 Fax: 330-253-6708 | |
Cecilia A. Ellis, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 605 N Cleveland Massillon Rd, Akron, OH 44333 Phone: 330-668-6545 Fax: 330-668-2726 | |
James Graham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 919 E Turkeyfoot Lake Rd Ste A, Akron, OH 44312 Phone: 330-899-9626 Fax: 330-633-6068 | |
John A. Black, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312 Phone: 330-344-8565 Fax: 330-896-7085 | |
Dr. Muriel Tabet, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
L Ann Nunnally, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 839 E Market St, Akron, OH 44305 Phone: 330-535-9191 |